Element Solutions Inc: Form 10-Q for the period ended Jun 30, 2018
Filed with the SEC on Aug 2, 2018 and accepted by EDGAR at Aug 2, 2018, 16:10 ET.
Management's discussion and analysis
As filed, 48,260 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
This Management's Discussion and Analysis of Financial Condition and Results of Operations section should be read in conjunction with the unaudited interim Condensed Consolidated Financial Statements and related notes included in this Quarterly Report, and the Consolidated Financial Statements, related notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations section and other disclosures contained in our 2017 Annual Report. This discussion contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements. Factors that might cause a difference include, but are not limited to, those discussed under "Forward-Looking Statements” and in Part II, Item 1A, "Risk Factors" of this Quarterly Report and in in Part I, Item 1A, "Risk Factors" of our 2017 Annual Report.
Executive Overview
Recent Developments
Announced Arysta Sale
On July 20, 2018, we entered into the Arysta Sale Agreement to sell our Agricultural Solutions business, which consists of Arysta and its subsidiaries, to UPL for $4.20 billion in cash, subject to adjustments. The Announced Arysta Sale is expected to close in late 2018 or early 2019, subject to customary closing conditions and regulatory approvals.
As a result of entering into the Arysta Sale Agreement, the Agricultural Solutions business is expected to be reported as a discontinued operation in the Company’s periodic filings beginning with its quarterly report on Form 10-Q for the three and nine months ended September 30, 2018. We expect to record an impairment charge of approximately $450 million to $550 million in the third quarter of 2018 primarily due to the recognition of foreign currency translation adjustments that have been recorded in Accumulated Other Comprehensive Loss within Stockholders’ Equity. The estimated range of the impairment charge above reflects our best estimate of the amount of the charge at June 30, 2018. The actual loss on sale will be dependent on a number of factors, including foreign exchange rates on the closing date of sale and other closing adjustments.
Board Approval of Share Repurchases of up to $750 million
The proceeds of the Announced Arysta Sale are expected to be used primarily to pay down a portion of our existing debt. We also may repurchase shares of our common stock in conjunction with the Board's authorization of up to $750 million in potential share repurchases, conditioned upon the closing of the Announced Arysta Sale. The timing, method and ultimate amount of any share repurchases cannot be determined at this time.
Intended Name Change
In connection with the Announced Arysta Sale, we announced our plan to change the name of the Company to Element Solutions Inc., effective at closing. We expect our shares of common stock to be traded on the NYSE under the ticker symbol “NYSE:ESI.”
New Board Director
On July 19, 2018, our Board elected Nichelle Maynard-Elliott to serve as a director of Platform, effective on August 15, 2018. Ms. Maynard-Elliott has not been appointed to any Board committee at this time.
Ms. Maynard-Elliott, 49, currently serves as Executive Director, Mergers & Acquisitions for Praxair, Inc. Ms. Maynard-Elliott joined Praxair in 2003 as Senior Counsel responsible for M&A and commercial transactions for Praxair's U.S. packaged gases and healthcare businesses. Ms. Maynard-Elliott served as Assistant General Counsel from 2007 to 2011 and transitioned to the role of Executive Director, M&A in 2011. She is admitted to practice law in New York and Connecticut. Ms. Maynard-Elliott graduated from Brown University with a B.A. in Economics, and received her J.D. from Columbia University School of Law.
Our Business
Platform, incorporated in Delaware in January 2014, is a global and diversified producer of high technology specialty chemical products. Our business involves the blending of a number of key ingredients to produce proprietary formulations. Utilizing our strong industry insight, process know-how, and creative research and development, we partner with our customers to provide innovative and differentiated solutions that are integral to their finished products. We operate in a wide variety of attractive niche markets across multiple industries, including automotive, agriculture, animal health, electronics, graphics, and offshore oil and gas production and drilling, and we believe that the majority of our operations hold strong positions in the product markets they serve. Our product innovations and product extensions are expected to continue to drive sales growth in both new and existing markets, while also expanding margins by continuing to offer high customer value propositions.
We have strong market positions in niche segments of high-growth markets and continually seek opportunities to act as an acquirer and consolidator of specialty chemical businesses, particularly those meeting our “Asset-Lite, High-Touch” philosophy, which involves prioritizing resources to research and development and offering highly technical sales and customer service, while managing conservatively our investments in fixed assets and capital expenditures. We regularly review acquisition opportunities and may acquire businesses that meet our acquisition criteria when we deem it to be financially prudent.
We generate revenue through the formulation and sale of our dynamic chemistries. In addition, we provide highly-technical service to our customers through our extensive global network of specially-trained service personnel. Our personnel follow up closely with our customers to ensure that the functional performance of our intricate chemical composition is maintained as intended and that these products are applied safely and effectively. Our specialty chemicals and processes are seen as integral to our customer’s product performance. We leverage these close customer relationships to execute our growth strategy and identify opportunities for new products. These new products are developed and created by drawing upon our intellectual property portfolio and technical expertise. We believe that our customers place significant value on our brands, which we capitalize on through innovation, product leadership and customer service.
Our operations are organized into two reportable segments: Performance Solutions and Agricultural Solutions. Both segments share a common focus on attractive niche markets, which we believe will grow faster than the diverse end-markets we serve.
Performance Solutions - The Performance Solutions segment formulates and markets dynamic chemistry solutions that are used in automotive production, electronics, commercial packaging and printing, and oil and gas production and drilling. Its products include surface and coating materials, water-based hydraulic control fluids, and photopolymers. In conjunction with the sale of its products, the segment provides extensive technical service and support when necessary to ensure superior performance of their application. While the segment's dynamic chemistries typically represent only a small portion of its customers’ costs, we believe that they are critical to its customers’ manufacturing processes and overall product performance. Further, operational risks and switching costs make it difficult for its customers to change suppliers and allow it to retain customers and maintain its market positions.
The segment provides specialty chemical solutions through the following five businesses:
| Assembly Solutions: | The business develops, manufactures and sells innovative interconnected materials, primarily in the electronics market, used to assemble printed circuit boards and advanced semiconductor packaging. |
| Electronics Solutions: | The business designs and formulates a complete line of proprietary “wet” dynamic chemistries used by customers to process the surface of printed circuit boards and other electronic components they manufacture. |
| Industrial Solutions | The business' dynamic chemistries are used for finishing, cleaning and providing surface coatings for a broad range of metal and non-metal surfaces which improve the performance or look of a component of an industrial part or process. |
| Graphics Solutions: | The business produces photopolymers, through an extensive line of flexographic plates, which are used to produce printing plates for transferring images onto commercial packaging, including packaging for consumer food products, pet food bags, corrugated boxes, labels and beverage containers. In addition, the segment produces photopolymer printing plates for the flexographic and letterpress newspaper and publications markets. |
| Offshore Solutions: | The business produces water-based hydraulic control fluids for major oil and gas companies and drilling contractors for offshore deep water production and drilling applications. |
Agricultural Solutions - The Agricultural Solutions segment specializes in the development, formulation, registration, marketing and distribution of differentiated Crop Protection solutions, including BioSolutions and Seed Treatment, for a variety of crops and applications. The segment's diverse Crop Protection chemicals control biotic stresses, such as weeds (herbicides), insects (insecticides) and diseases (fungicides). Its portfolio of proven BioSolutions includes BioStimulants, which are derived from natural substances applied to plants, seeds or the soil in order to enhance yields and help crops withstand abiotic stress, such as drought or cold, and BioControl products, which perform the same task as conventional Crop Protection products with, in many cases, the added benefit of reduced chemical residues. The segment's solutions are offered in multiple forms, such as foliar applications (direct application to leaves), furrow treatment (treatment of soil trenches or grooves wherein seeds are sown) or Seed Treatment (seed coating prior to planting). Its products allow it to partner with growers to address the ever-increasing need for higher crop yield and food quality.
The segment categorizes its products in three core portfolios:
| Crop Protection: | The Crop Protection business is one of the largest Crop Protection chemical companies by revenue. Its diverse Crop Protection chemicals control biotic stresses, such as diseases (fungicides), weeds (herbicides) and insects (insecticides). |
| BioSolutions: | The segment believes its BioSolutions business has a strong position as innovator in BioSolutions and BioStimulants. These products are derived from natural sources that fall into several categories: biological stimulants (BioStimulants), Innovative Nutrition and biological control (BioControl). This portfolio is highly differentiated through innovative technologies and mixtures and primarily protected by trade secrets. |
| Seed Treatment: | The segment's diverse Seed Treatments are applied before planting by coating the seed in order to protect it during germination and protect the plant during its initial growth phases. The segment anticipates growth in Seed Treatments as a result of the increasing value of seeds and the use of higher-value genetically-modified seeds. |
Recent Accounting Pronouncements
A summary of recent accounting pronouncements in included in Note 2, Recent Accounting Pronouncements, to our unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report.
Results of Operations
Three and six months ended June 30, 2018 as compared to the three and six months ended June 30, 2017
The following table summarizes our results of operations for the three and six months ended June 30, 2018 and 2017:
($ amounts in millions)
| Three Months Ended June 30, 2018 | 2017 | % Change Reported | Constant Currency | Organic | Six Months Ended June 30, 2018 | 2017 | % Change Reported | Constant Currency | Organic | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales | $1,022.5 | $941.1 | 9% | 8% | 7% | $1,986.6 | $1,802.9 | 10% | 6% | 6% |
| Cost of sales | 599.6 | 541.2 | 11% | 10% | 1,159.0 | 1,024.6 | 13% | 9% | ||
| Gross profit | 422.9 | 399.9 | 6% | 4% | 827.6 | 778.3 | 6% | 2% | ||
| Selling, technical, general and administrative | 280.0 | 284.3 | (2)% | (3)% | 557.0 | 541.7 | 3% | —% | ||
| Research and development | 25.9 | 25.1 | 3% | 3% | 49.4 | 46.7 | 6% | 4% | ||
| Operating profit | 117.0 | 90.5 | 29% | 26% | 221.2 | 189.9 | 16% | 7% | ||
| Interest expense, net | (79.5) | (85.0) | (6)% | (157.7) | (174.4) | (10)% | ||||
| Foreign exchange (loss) gain | (52.2) | (59.9) | (13)% | 5.8 | (72.5) | (nm) | ||||
| Other income, net | 11.9 | 5.5 | (nm) | 30.9 | 3.2 | (nm) | ||||
| Income tax benefit (expense) | 14.6 | (11.1) | (nm) | (50.4) | (29.8) | 69% | ||||
| Net income (loss) | $11.8 | $(60.0) | (nm) | $49.8 | $(83.6) | (nm) |
(nm) Calculation not meaningful.
Non-GAAP Financial Measures
To supplement our financial results presented in accordance with GAAP in this Management’s Discussion and Analysis of Financial Condition and Results of Operations section, we present certain non-GAAP financial measures, such as operating results on a constant currency basis and organic sales growth. Management internally reviews each of these non-GAAP measures to evaluate performance on a comparative period-to-period basis in terms of absolute performance, trends and expected future performance with respect to our business. We believe these non-GAAP financial measures, which are each further described below, provide investors with an additional perspective on trends and underlying operating results on a period-to-period comparable basis. We also believe that investors find this information helpful in understanding the ongoing performance of our operations separate from items that may have a disproportionate positive or negative impact on our financial results in any particular period or are considered to be costs associated with our capital structure.
These non-GAAP financial measures, however, have limitations as analytical tools, and should not be considered in isolation from, or a substitute for, or superior to, the related financial information that we report in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements, and may not be comparable to similarly titled measures of other companies due to potential differences in calculation methods. In addition, these measures are subject to inherent limitations as they reflect the exercise of judgment by management about which items are excluded or included in determining these non-GAAP financial measures. Investors are encouraged to review the reconciliations of these non-GAAP financial measures to their most comparable GAAP financial measures included in this Quarterly Report, and not to rely on any single financial measure to evaluate the Company's businesses.
Constant Currency
We disclose operating results from net sales through operating profit on a constant currency basis by adjusting to exclude the impact of changes due to the translation of foreign currencies of our international locations into U.S. dollars. Management believes this non-GAAP financial information facilitates period-to-period comparison in the analysis of trends in business performance, thereby providing valuable supplemental information regarding our results of operations, consistent with how we internally evaluate our financial results.
The impact of foreign currency translation is calculated by converting our current-period local currency financial results into U.S. dollars using the prior period's exchange rates and comparing these adjusted amounts to our prior period reported results. The difference between actual growth rates and constant currency growth rates represents the impact of foreign currency translation. The foreign exchange impacts on the quarter-to-date and year-to-date results were primarily the result of appreciation in the euro, partially offset by depreciation in the Brazilian real.
Organic Sales Growth
Organic sales growth is defined as net sales excluding the impact of foreign currency translation, changes due to the price of certain metals, and acquisitions and/ or divestitures, as applicable. Management believes this non-GAAP financial measure provides investors with a more complete understanding of the underlying net sales trends by providing comparable sales over differing periods on a consistent basis.
The following table reconciles GAAP net sales growth to organic sales growth for the three and six months ended June 30, 2018:
| Three Months Ended June 30, 2018 Reported Net Sales Growth | Impact of Currency | Metals | Acquisitions | Organic Sales Growth | |
|---|---|---|---|---|---|
| Performance Solutions | 9% | (3)% | —% | —% | 5% |
| Agricultural Solutions | 9% | 1% | —% | —% | 10% |
| Total | 9% | (1)% | —% | —% | 7% |
| Six Months Ended June 30, 2018 | |||||
| Reported Net Sales Growth | Impact of Currency | Metals | Acquisitions | Organic Sales Growth | |
| Performance Solutions | 9% | (5)% | —% | —% | 4% |
| Agricultural Solutions | 11% | (3)% | —% | —% | 8% |
| Total | 10% | (4)% | —% | —% | 6% |
NOTE: Totals may not sum due to rounding.
For the six months ended June 30, 2018, metals pricing had a negative impact on Performance Solutions' results and our consolidated results of $2.6 million. For the three months ended June 30, 2018, the metals pricing impact was immaterial.
For the three and six months ended June 30, 2018, acquisitions had a positive impact of $1.2 million on Performance Solutions' results, $0.6 million on Agricultural Solutions' results, and $1.8 million on our consolidated results.
Net Sales
($ amounts in millions)
| Net sales | Three Months Ended June 30, 2018 | 2017 | % Change Reported | Constant Currency | Organic | Six Months Ended June 30, 2018 | 2017 | % Change Reported | Constant Currency | Organic |
|---|---|---|---|---|---|---|---|---|---|---|
| Performance Solutions | $501.7 | $462.3 | 9% | 5% | 5% | $994.1 | $909.4 | 9% | 4% | 4% |
| Agricultural Solutions | 520.8 | 478.8 | 9% | 10% | 10% | 992.5 | 893.5 | 11% | 8% | 8% |
| Total | $1,022.5 | $941.1 | 9% | 8% | 7% | $1,986.6 | $1,802.9 | 10% | 6% | 6% |
Performance Solutions' net sales in the second quarter of 2018 increased by 9% (5% on a constant currency and organic basis). Organic net sales increased across all of our businesses, driven largely by our Industrial, Offshore and Assembly businesses. Our Industrial business contributed approximately 2% to the segment's organic sales growth as strong demand for film products in the Americas and Asia, coupled with broad growth in Europe, resulted in solid volume gains. Demand in our Offshore business benefited from improved business conditions in offshore drilling markets and higher fill activity in the period, particularly in the Americas. Growth in our Assembly business was driven primarily by continued volume increases in solder paste and bar products in the Americas and Asia. Growth in our Electronics business was driven primarily by core electronics products in the Americas and Europe, as well as broad strength in advances electronics, partially offset by softness in mobile products in Asia.
On a year-to-date basis, Performance Solutions' net sales increased by 9% (4% on a constant currency and 4% on an organic basis). Organic sales growth in our Industrial business benefited from strong growth of surface treatment chemistries in Europe and Asia, and film products in the Americas and Asia. Our Assembly business contributed broadly across product lines, particularly solder paste and bar products in Asia and the Americas. Organic sales growth in our Electronics business was driven primarily by higher semiconductor and core electronics sales volume across Asia, as well as market share gains in North America.
Agricultural Solutions' net sales in the second quarter of 2018 increased by 9% (10% on a constant currency and organic basis). Organic net sales growth was driven primarily by our businesses in LATAM and, to a lesser extent, NAANZ. The growth in LATAM was led by new product growth in Brazil and Mexico, strong demand for existing herbicide products throughout the region, as well as price increases due to the weaker Brazilian real. New herbicide products in the US and Australia significantly contributed to the growth in NAANZ, with fungicides providing additional gains in the US. Europe had modest growth in the quarter despite unfavorable weather conditions.
On a year-to-date basis, Agricultural Solutions' net sales increased by 11% (8% on a constant currency and organic basis). This overall performance was driven by significant growth in LATAM as a result of the late start of the selling season in Brazil, particularly for row crop products, as well as price increases due to the weaker Brazilian real. Our continued geographic expansion into various European markets, most notably in parts of Eastern Europe, Germany and the United Kingdom, and new product introductions across Europe and parts of Latin America also contributed to the segment's performance. In addition, organic growth in NAANZ was driven by sales of fungicides in the United States and herbicides in Australia. These increases were partially offset by lower sales volumes in parts of Central and Eastern Europe and Canada.
Gross Profit
($ amounts in millions)
| Gross profit | Three Months Ended June 30, 2018 | 2017 | % Change Reported | Constant Currency | Six Months Ended June 30, 2018 | 2017 | % Change Reported | Constant Currency |
|---|---|---|---|---|---|---|---|---|
| Performance Solutions | $214.7 | $196.6 | 9% | 6% | $425.8 | $393.4 | 8% | 4% |
| Agricultural Solutions | 208.2 | 203.3 | 2% | 2% | 401.8 | 384.9 | 4% | —% |
| Total | $422.9 | $399.9 | 6% | 4% | $827.6 | $778.3 | 6% | 2% |
| Gross margin | ||||||||
| Performance Solutions | 42.8% | 42.5% | 30 bps | 40 bps | 42.8% | 43.3% | (50) bps | (20) bps |
| Agricultural Solutions | 40.0% | 42.5% | (250) bps | (300) bps | 40.5% | 43.1% | (260) bps | (320) bps |
| Total | 41.4% | 42.5% | (110) bps | (140) bps | 41.7% | 42.7% | (100) bps | (170) bps |
Performance Solutions' gross profit in the second quarter of 2018 increased by 9% (6% at constant currency). Constant currency growth was driven primarily by higher revenues in our Offshore business and a favorable product mix in our Assembly business. This growth was partially offset by unfavorable product mix in our Electronics business, which recorded a lower proportion of high-margin product sales, most notably in Asia.
On a year-to-date basis, Performance Solutions' gross profit increased by 8% (4% at constant currency). The primary driver of the increase in constant currency gross profit and gross margin was an increase in the year-to-date sales growth discussed above. This growth was partially offset by margin decline resulting primarily from unfavorable product mix in our Electronics business, which recorded a lower proportion of high-margin product sales, most notably in Asia, the impact of certain raw material price inflation year-over-year and increases in logistics and warehousing costs resulting from our plant rationalization initiatives.
Agricultural Solutions' gross profit in the second quarter of 2018 increased by 2% on a reported and constant currency basis. The increase was mainly the result of volume gains in Brazil, North America and Australia as discussed above. This growth was partially muted by margin erosion resulting from AI price inflation driven by tighter supply from China, pricing pressures from generic products in North America and continued unfavorable product mix in parts of Europe.
On a year-to-date basis, Agricultural Solutions' gross profit increased by 4% and remained relatively unchanged at constant currency as AI price inflation, which was driven by tighter supply from China, pricing pressures from generic products in North America and unfavorable product mix in parts of Europe, Asia and NAANZ, mostly offset volume gains and favorable product mix in LATAM.
Selling, Technical, General and Administrative Expense (STG&A)
($ amounts in millions)
| STG&A | Three Months Ended June 30, 2018 | 2017 | % Change Reported | Constant Currency | Six Months Ended June 30, 2018 | 2017 | % Change Reported | Constant Currency |
|---|---|---|---|---|---|---|---|---|
| Performance Solutions | $127.4 | $124.1 | 3% | —% | $250.1 | $242.8 | 3% | (1)% |
| Agricultural Solutions | 131.6 | 140.6 | (6)% | (6)% | 264.9 | 259.7 | 2% | —% |
| Corporate | 21.1 | 19.7 | 7% | 7% | 42.0 | 39.2 | 7% | 7% |
| Total | $280.0 | $284.4 | (2)% | (3)% | $557.0 | $541.7 | 3% | —% |
| STG&A as a % of net sales | ||||||||
| Performance Solutions | 25.4% | 26.8% | (140) bps | (140) bps | 25.2% | 26.7% | (150) bps | (140) bps |
| Agricultural Solutions | 25.3% | 29.4% | (410) bps | (430) bps | 26.7% | 29.1% | (240) bps | (220) bps |
| Total | 27.4% | 30.2% | (280) bps | (290) bps | 28.0% | 30.0% | (200) bps | (180) bps |
Performance Solutions' STG&A in the second quarter of 2018 increased by 3% (relatively unchanged at constant currency) as a reduction in integration costs offset higher selling costs associated with the increased sales volumes.
On a year-to-date basis, Performance Solutions' STG&A increased by 3% (decreased 1% at constant currency). The decrease in constant currency STG&A expense was the result of higher costs in the prior year associated with the integration of prior acquisitions and restructuring, partially offset by operating cost inflation and higher selling costs.
Agricultural Solutions' STG&A in the second quarter of 2018 decreased by 6% on a reported and constant currency basis primarily due to lower year-over-year bad debt provisions and $4.8 million of lower costs associated with non-recourse factoring programs and cost savings initiatives. In addition, the prior year included $3.3 million of expense related to our notice of termination of a long-term supply agreement related to the acquisition of the Chemtura AgroSolutions business from Chemtura Corporation in 2014. These reductions were partially offset by $3.5 million of accelerated amortization related to certain product registration rights, costs associated with continued expansion in certain European markets and operating cost inflation.
On a year-to-date basis, Agricultural Solutions' STG&A increased by 2%, but remained relatively unchanged at constant currency as higher year-over-year incentive compensation expense, operating cost inflation and costs associated with continued expansion in certain European markets were almost entirely offset by lower year-over-year bad debt provisions, $4.4 million of lower costs associated with non-recourse factoring programs and cost savings initiatives.
Corporate's STG&A in the second quarter of 2018 increased by 7% on a reported and constant currency basis. The increase was primarily due to higher costs associated with the Announced Arysta Sale.
On a year-to-date basis, Corporate's STG&A increased by 7% on a reported and constant currency basis. The increase was primarily due to higher costs associated with the Announced Arysta Sale, offset in part by senior executive severance costs incurred in the prior year.
Research and Development Expense (R&D)
($ amounts in millions)
| R&D | Three Months Ended June 30, 2018 | 2017 | % Change Reported | Constant Currency | Six Months Ended June 30, 2018 | 2017 | % Change Reported | Constant Currency |
|---|---|---|---|---|---|---|---|---|
| Performance Solutions | $11.2 | $11.6 | (4)% | (4)% | $22.6 | $22.6 | —% | (1)% |
| Agricultural Solutions | 14.7 | 13.5 | 9% | 9% | 26.9 | 24.1 | 11% | 9% |
| Total | $25.9 | $25.1 | 3% | 3% | $49.4 | $46.7 | 6% | 4% |
| R&D as a % of net sales | ||||||||
| Performance Solutions | 2.2% | 2.5% | (30) bps | (20) bps | 2.3% | 2.5% | (20) bps | (10) bps |
| Agricultural Solutions | 2.8% | 2.8% | — bps | — bps | 2.7% | 2.7% | — bps | — bps |
| Total | 2.5% | 2.7% | (20) bps | (10) bps | 2.5% | 2.6% | (10) bps | — bps |
Operating Profit
($ amounts in millions)
| Operating profit | Three Months Ended June 30, 2018 | 2017 | % Change Reported | Constant Currency | Six Months Ended June 30, 2018 | 2017 | % Change Reported | Constant Currency |
|---|---|---|---|---|---|---|---|---|
| Performance Solutions | $76.1 | $61.0 | 25% | 21% | $153.1 | $128.2 | 19% | 14% |
| Agricultural Solutions | 61.9 | 49.2 | 26% | 24% | 110.0 | 101.1 | 9% | (1)% |
| Corporate | (21.1) | (19.7) | 7% | 7% | (42.0) | (39.4) | 7% | 7% |
| Total | $117.0 | $90.5 | 29% | 26% | $221.2 | $189.9 | 16% | 7% |
| Operating margin | ||||||||
| Performance Solutions | 15.2% | 13.2% | 200 bps | 200 bps | 15.4% | 14.1% | 130 bps | 130 bps |
| Agricultural Solutions | 11.9% | 10.3% | 160 bps | 130 bps | 11.1% | 11.3% | (20) bps | (100) bps |
| Total | 11.4% | 9.6% | 180 bps | 160 bps | 11.1% | 10.5% | 60 bps | 10 bps |
Performance Solutions' operating profit in the second quarter of 2018 increased by 25% (21% at constant currency), representing an operating margin of 15.2%. The increase in constant currency operating profit and margin was driven primarily by the higher gross profit and gross margin noted above, combined with reduced operating expenses.
On a year-to-date basis, Performance Solutions' operating profit increased by 19% (14% at constant currency) to an operating margin of 15.4%. The increase in constant currency operating profit and margin was driven primarily by higher gross profit and lower operating expenses noted above.
Agricultural Solutions' operating profit in the second quarter of 2018 increased by 26% (24% at constant currency), representing an operating margin of 11.9%. The increase in constant currency operating profit was driven primarily by lower STG&A expenses and higher gross profit noted above. Operating margin was higher, as lower STG&A more than offset gross margin pressure.
On a year-to-date basis, Agricultural Solutions' operating profit increased by 9% (decreased 1% at constant currency) to an operating margin of 11.1%. The decrease in constant currency operating profit resulted from a slight increase in STG&A costs. Operating margin declined due to the gross margin declines noted above.
Total Other (Expense) Income
(amounts in millions)
| Other (expense) income | Three Months Ended June 30, 2018 | 2017 | Six Months Ended June 30, 2018 | 2017 |
|---|---|---|---|---|
| Interest expense, net | $(79.5) | $(85.0) | $(157.7) | $(174.4) |
| Foreign exchange (loss) gain | (52.2) | (59.9) | 5.8 | (72.5) |
| Other income, net | 11.9 | 5.5 | 30.9 | 3.2 |
| Total | $(119.8) | $(139.4) | $(121.0) | $(243.7) |
Interest Expense, Net
For the three months ended June 30, 2018 and 2017, net interest expense totaled $79.5 million and $85.0 million, respectively. For the six months ended June 30, 2018 and 2017, net interest expense totaled $158 million and $174 million, respectively. The decrease in net interest expense, both in the quarter and year-to-date, was primarily driven by the redemption of our 10.375% senior notes and the repricing of a portion of our term loans in 2017, which decreased the weighted average effective interest rate on our Senior Notes from approximately 7.8% at June 30, 2017 to 6.5% at June 30, 2018, and on our term loans from approximately 5.0% at June 30, 2017 to 4.6% at June 30, 2018.
Foreign Exchange (Loss) Gain
For the three months ended June 30, 2018 and 2017, foreign exchange loss totaled $52.2 million and $59.9 million, respectively. For the six months ended June 30, 2018 and 2017, foreign exchange gain (loss) totaled $5.8 million and $(72.5) million, respectively. The change in foreign exchange losses and gains for both periods presented was primarily related to the remeasurement of yen and euro denominated intercompany balances and euro denominated debt balances to U.S. dollar.
Other Income, Net
For the three months ended June 30, 2018 and 2017, other income, net totaled $11.9 million and $5.5 million, respectively. This quarterly change was primarily due to a $12.9 million gain on foreign exchange derivative contracts in 2018, as well as a reduction in debt extinguishment costs of approximately $7.8 million from prior year, partially offset by a $4.0 million impairment charge on a cost method investment recorded during the quarter and a favorable legal settlement of $10.6 million recognized in the prior year.
For the six months ended June 30, 2018 and 2017, other income, net totaled $30.9 million and $3.2 million, respectively. This year-over-year change was primarily related to a gain on the sale of an equity investment of $11.3 million, a $10.9 million gain on foreign exchange derivative contracts, a $4.8 million favorable adjustment to our ARO reserve, as well as a $3.7 million insurance gain. The ARO relates to a facility that is in the process of closing in connection with a previously terminated supply agreement related to the acquisition of the Chemtura AgroSolutions business from Chemtura Corporation in 2014, as current cost estimates are lower than initially projected. Prior year activity included a favorable legal settlement of $10.6 million which was largely offset by $7.8 million of debt extinguishment costs.
Income Tax
(amounts in millions)
| Income tax | Three Months Ended June 30, 2018 | 2017 | Six Months Ended June 30, 2018 | 2017 |
|---|---|---|---|---|
| Income tax benefit (expense) | $14.6 | $(11.1) | $(50.4) | $(29.8) |
| Effective tax rate | 521.4% | (22.7)% | 50.3% | (55.4)% |
For the three months ended June 30, 2018 and 2017, income tax benefit (expense) totaled $14.6 million and $(11.1) million, respectively. For the six months ended June 30, 2018 and 2017, income tax expense totaled $50.4 million and $29.8 million, respectively. The change in income tax expense in both periods was largely driven by an increase in pre-tax income and the change in recognition of valuation allowances on net operating losses that may not be recoverable for U.S. and foreign companies.
Other Comprehensive Income
Other comprehensive loss for the three months ended June 30, 2018 totaled $375 million, as compared to $40.4 million in the prior year. The change was driven primarily by foreign currency translation losses associated with the euro, Brazilian real and Chinese Yuan partially offset by gains associated with the British pound.
For the six months ended June 30, 2018, other comprehensive loss totaled $310 million, compared to income of $141 million in the prior year. The change was driven primarily by foreign currency translation losses associated with the Brazilian real, euro and Canadian dollar partially offset by gains associated with the British pound.
Segment Performance
Our operations are organized into two reportable segments: Performance Solutions and Agricultural Solutions. Both segments share a common focus on attractive niche markets, which we believe will grow faster than the diverse end-markets we serve. For additional information regarding our segments, see Part I, Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations, under "Executive Overview - Our Business," and Note 16, Segment Information, to our unaudited interim Condensed Consolidated Financial Statements, included in this Quarterly Report.
Adjusted EBITDA
We utilize Adjusted EBITDA as one of the measures to evaluate the performance of our operating segments. Adjusted EBITDA for each segment includes an allocation of corporate costs, such as compensation expense and professional fees. See Note 16, Segment Information, to our unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report, for more information and a reconciliation of Net income (loss) attributable to common stockholders to Adjusted EBITDA.
($ amounts in millions)
| Adjusted EBITDA | Three Months Ended June 30, 2018 | 2017 | % Change Reported | Constant Currency | Six Months Ended June 30, 2018 | 2017 | % Change Reported | Constant Currency |
|---|---|---|---|---|---|---|---|---|
| Performance Solutions | $116.6 | $102.7 | 14% | 10% | $228.4 | $205.0 | 11% | 6% |
| Agricultural Solutions | 109.4 | 102.5 | 7% | 6% | 204.8 | 193.3 | 6% | (1)% |
| Total | $226.0 | $205.2 | 10% | 8% | $433.2 | $398.3 | 9% | 3% |
| Adjusted EBITDA as a % of net sales | ||||||||
| Performance Solutions | 23.2% | 22.2% | 100 bps | 100 bps | 23.0% | 22.5% | 50 bps | 40 bps |
| Agricultural Solutions | 21.0% | 21.4% | (40) bps | (80) bps | 20.6% | 21.6% | (100) bps | (170) bps |
| Total | 22.1% | 21.8% | 30 bps | 0 bps | 21.8% | 22.1% | (30) bps | (70) bps |
Performance Solutions' Adjusted EBITDA in the second quarter of 2018 increased 14% (10% at constant currency). The constant currency increase and margin expansion was driven primarily by gross profit growth in our Assembly and Offshore businesses combined with the containment of operating expenses, as noted above.
On a year-to-date basis, Performance Solutions' Adjusted EBITDA increased 11% (6% at constant currency). The constant currency increase and margin expansion was driven primarily by gross profit growth in our Assembly and Electronics businesses combined with the containment of operating expenses, as noted above.
Agricultural Solutions' Adjusted EBITDA in the second quarter of 2018 increased 7% (6% at constant currency). The increase in constant currency Adjusted EBITDA was driven primarily by an increase in gross profit, most notably in LATAM, and a reduction in STG&A expenses, as noted above. These were partially offset by transactional foreign exchange losses. The reduction in margin was driven by AI cost increases combined with some pricing pressures, as noted above.
On a year-to-date basis, Agricultural Solutions' Adjusted EBITDA increased 6% (decreased 1% at constant currency). The constant currency decrease and margin reduction was driven primarily by slight increases in operating expenses as well as transactional foreign exchange losses, partially offset by slightly higher gross profit, as noted above.
Liquidity and Capital Resources
At June 30, 2018, our indebtedness totaled $5.54 billion, of which $1.31 billion consisted of term loans under our Amended and Restated Credit Agreement which will become due in 2020. As a result of our interest rate swaps, approximately 68% of our debt is fixed, with the remaining balance subject to fluctuations in the one-month LIBOR and EURIBOR. The expected interest payments on our Senior Notes and term loans total approximately $275 million per year over the next two years prior to the potential effect on our capital structure of the Announced Arysta Sale.
Our primary sources of liquidity during the six months ended June 30, 2018 were periodic borrowings under our Revolving Credit Facility and available cash generated from operations. Our primary uses of cash and cash equivalents were to fund operations, working capital, capital expenditures and debt service obligations. We believe that our cash and cash equivalents and cash generated from operations, supplemented by availability under our lines of credit, including our Revolving Credit Facility, will be sufficient to meet our working capital needs, interest payments, capital expenditures and other business requirements for at least the next twelve months. However, working capital cycles and future acquisitions may require additional funding, which may include proceeds from future debt and/or equity offerings. Our long-term liquidity may be influenced by our ability to borrow additional funds, renegotiate existing debt and raise equity under terms that are favorable to us.
During the six months ended June 30, 2018, approximately 83% of our net sales was generated from non-U.S. operations. We expect to continue to generate significant revenue from non-U.S. operations and, as a result, have a substantial portion of our cash held predominately by our foreign subsidiaries. We expect to manage our worldwide cash requirements based on available funds among the many subsidiaries through which we conduct business and the cost effectiveness with which those funds can be accessed. We may transfer cash from certain international subsidiaries to the United States and other international subsidiaries when we believe it is cost effective to do so.
We continually review our domestic and foreign cash profile, expected future cash generation and investment opportunities, which support our current designation of a portion of these funds as being indefinitely reinvested and reassess whether there is a demonstrated need to repatriate funds held internationally. If, as a result of our review, it is determined that all or a portion of the funds require repatriation, we may be required to accrue additional foreign taxes. Of our $442 million of cash and cash equivalents at June 30, 2018, $405 million were held by our foreign subsidiaries.
We may from time to time seek to repurchase or redeem our outstanding debt, including, but not limited to, our Senior Notes, through cash purchases and/or exchanges for equity securities, in open market purchases, privately negotiated transactions or otherwise if we believe that it is in our best interests. We may also seek to reduce interest expense and extend debt maturities. Such transactions, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions, applicable restrictions under our various financing arrangements and other factors. The proceeds of the Announced Arysta Sale, which is expected to close in late 2018 or in early 2019, subject to customary closing conditions and regulatory approvals, are expected to be used primarily to pay down a portion of our existing debt.
The following is a summary of our cash flows (used in) provided by operating, investing, and financing activities during the periods indicated:
(amounts in millions)
| Six Months Ended June 30, 2018 | 2017 | |
|---|---|---|
| Cash, cash equivalents and restricted cash, beginning of the period | $483.9 | $423.5 |
| Cash used in operating activities | (91.7) | (10.3) |
| Cash used in investing activities | (32.7) | (45.4) |
| Cash provided by financing activities | 103.2 | 42.0 |
| Exchange rate impact on cash, cash equivalents and restricted cash | (15.8) | 18.4 |
| Cash, cash equivalents and restricted cash, end of the period | $446.9 | $428.2 |
Operating Activities
During the six months ended June 30, 2018, cash used in operating activities totaled $91.7 million, compared to $10.3 million used during the six months ended June 30, 2017. This $81.4 million increased use of cash in operating activities was driven primarily by timing of working capital, offset in part by higher cash operating profits (net income (loss) adjusted for non-cash items). The increased use of cash for working capital was primarily due to higher accounts receivable and inventory balances mainly driven by stronger relative performance in LATAM and market softness in Europe, both within our Agricultural Solutions segment.
Investing Activities
Cash flows used in investing activities totaled $32.7 million during the six months ended June 30, 2018, as compared to $45.4 million used during the six months ended June 30, 2017. The $12.7 million decreased use of cash in investing activities was driven primarily by $31.8 million of higher proceeds from the beneficial interests of our nonrecourse factoring arrangements, as the primary program with this feature was first introduced late during the second quarter of 2017, and $25.0 million of proceeds from the sale of an equity investment in 2018, offset in part by $50.0 million spent on two acquisitions in the quarter.
Financing Activities
Cash flows provided by financing activities totaled $103 million during the six months ended June 30, 2018, as compared to $42.0 million provided by financing activity during the six months ended June 30, 2017. This $61.2 million increase was primarily driven by $36.4 million of higher year-over-year net borrowings under our lines of credit and $18.7 million of lower year-over-year net debt repayments.
Financial Borrowings
Credit Facilities
At June 30, 2018, we had $5.54 billion of indebtedness, which primarily included:
- $2.28 billion of Senior Notes;
- $3.12 billion of term debt arrangements outstanding under our First Lien Credit Facility; and
- $126 million of borrowings under local and revolving lines of credit.
Availability under our Revolving Credit Facility and various lines of credit and overdraft facilities totaled $503 million at June 30, 2018 (including $24.8 million of stand-by letters of credit which reduced the borrowings available under our Revolving Credit Facility).
Covenants
Our Credit Facilities contain various affirmative and negative covenants, including limitations on additional indebtedness, dividends and other distributions, entry into new lines of business, use of loan proceeds, capital expenditures, restricted payments, restrictions on liens, transactions with affiliates, amendments to organizational documents, accounting changes, sale and leaseback transactions, and dispositions. Our Revolving Credit Facility requires compliance with certain financial covenants, including a first lien net leverage ratio of no greater than 6.25 to 1.0 of (x) consolidated indebtedness secured by a first lien minus unrestricted cash and cash equivalents of the borrowers and guarantors under the Amended and Restated Credit Agreement to (y) consolidated EBITDA for the four most recent fiscal quarters; provided that in the event that the Company or certain of its subsidiaries (i) incur incremental facilities in an aggregate amount in excess of $250 million or (ii) make restricted payments in an aggregate amount in excess of $50 million, the first lien net leverage ratio will be reduced to 4.0 to 1.0, in each case subject to a right to cure. In addition, our Amended and Restated Credit Agreement requires a prepayment percentage in the case of excess cash flow, both calculated as set forth in the Amended and Restated Credit Agreement, of 75% with step-downs to 50%, 25% and 0% based on the applicable first lien net leverage ratio on the prepayment date.
Lastly, our Senior Notes are governed by indentures which also provide, among other things, for customary affirmative and negative covenants, events of default, and other customary provisions.
Off-Balance Sheet Transactions
We use customary off-balance sheet arrangements, such as non-recourse factoring arrangements, letters of credit and operating leases to finance our business. For additional information regarding non-recourse factoring arrangements and letters of credit, see Note 9, Debt, Factoring and Customer Financing Arrangements, to our unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report.
As a result of ASU No. 2016-02, “Leases,” for fiscal years and interim periods beginning after December 15, 2018, we will be required to record lease liabilities and right-of-use assets for all of our qualifying operating leases that are currently treated as off-balance sheet transactions.
Market risk
As filed, 335 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The quantitative and qualitative disclosures about market risk required by this item have not changed materially from those disclosed in our 2017 Annual Report. For a discussion of our exposure to market risk, refer to Part II, Item 7A, "Quantitative and Qualitative Disclosures about Market Risk," contained in our 2017 Annual Report.
Controls and procedures
As filed, 4,385 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
(a) Evaluation of Disclosure Controls and Procedures
Our management is responsible for establishing and maintaining disclosure controls and procedures as defined in Rules 13a-15 (e) and 15d-15(e) under the Exchange Act. As required by Rule 13a-15(b) of the Exchange Act, management, including our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, our CEO and CFO have concluded that the Company’s disclosure controls and procedures were not effective due to the previously-reported material weakness in our internal control over financial reporting relating to the accounting for income taxes, as described more fully in Part II, Item 9A, Controls and Procedures, of our 2017 Annual Report.
The material weakness in our internal control relating to the accounting for income taxes continued to exist as of the end of the period covered by this Quarterly Report and our management continues to be actively engaged in implementing the remediation initiatives described in our 2017 Annual Report. Our ongoing remediation efforts to improve, design and implement integrated processes to enhance our internal control over the accounting for income taxes include the implementation of the following previously stated initiatives:
- improving the overall tax provision process; and
- enhancing our income tax controls to include specific activities to assess the accounting for significant complex transactions and other tax related judgments.
While we believe that significant progress continues to be made, additional time is necessary to fully implement and demonstrate the effectiveness of these remediation initiatives and until remediated, the material weakness described above could result in material misstatements of our annual or interim consolidated financial statements that would not be prevented or detected. We are committed to operating effective controls, and management continues to regularly assess the progress and sufficiency of the ongoing initiatives and make adjustments as and when necessary. Our remediation efforts are also subject to ongoing Audit Committee oversight. Our goal is to remediate this material weakness concurrently with the filing of our annual report on Form 10-K for the year ended December 31, 2018.
Notwithstanding the aforementioned material weakness, our management believes that the unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report fairly represent, in all material respects, our results of operations, financial position and cash flows as of and for the periods presented, each in accordance with GAAP. Based in part on our continuing efforts, our CEO and CFO have included their certifications as exhibits to this Quarterly Report.
(b) Changes to Internal Control Over Financial Reporting
As required by Rule 13a-15(d) under the Exchange Act, our management, including our CEO and CFO, has evaluated the Company’s internal control over financial reporting to determine whether any changes occurred during the quarter covered by this Quarterly Report have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
There have been no significant changes in our internal control over financial reporting that occurred during the quarter covered by this Quarterly Report that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 5,221 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Except as set forth below, there have been no material changes to the risk factors set forth in Part I, Item 1A of our 2017 Annual Report under the heading “Risk Factors.”
We and UPL may be unable to obtain the regulatory approvals or satisfy the other closing conditions required to complete the Announced Arysta Sale, which could impact our financial condition, results of operations, prospects and/or stock price.
The completion of the Announced Arysta Sale is subject to closing conditions, including the expiration or early termination of the applicable waiting period (or extension thereof) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, as well as approvals from antitrust authorities from certain non-U.S. jurisdictions and of certain other governmental authorities. We and UPL are pursuing all required consents, clearances and authorizations in accordance with the Arysta Sale Agreement. However, no assurance can be given that the required consents, clearances and authorizations will be obtained and, even if all such consents, clearances and authorizations are obtained, no assurance can be given as to the terms, conditions and timing of the consents, clearances and authorizations. These consents, clearances and authorizations may also impose conditions, which may delay or impair the parties' ability to complete the Announced Arysta Sale.
Further, even if all such consents, clearances and authorizations are obtained and such conditions are satisfied, no assurance can be given that the other conditions required to complete the Announced Arysta Sale will be satisfied, by us or UPL. The Arysta Sale Agreement may also be terminated by us and UPL in certain specified circumstances, including if the closing of the Announced Arysta Sale does not occur on or prior to December 31, 2019, subject to certain extension rights. If the Arysta Sale Agreement is terminated, we may not be able to negotiate another transaction on terms comparable to, or better than, the terms of the Arysta Sale Agreement.
The failure of the Announced Arysta Sale to close on a timely basis, or at all, could have a material adverse effect on our financial condition and/or stock price.
The announcement and pendency of the closing of the Announced Arysta Sale to UPL could have an adverse effect on our business, results of operations, financial condition, prospects and/or stock price.
The announcement and pendency of the closing of the Announced Arysta Sale, which is expected to occur late in late 2018 or in early 2019, could disrupt our business and/or our stock price in the following ways, among others:
- our current or prospective customers may experience uncertainty associated with the Announced Arysta Sale and may delay or defer purchase decisions with regard to our products;
- our customers, distributors and lenders may also attempt to terminate and/or renegotiate their relationships with us, whether pursuant to the terms of their existing agreements with us or otherwise;
- uncertainties related to the Announced Arysta Sale may impair our ability to attract, retain and motivate key personnel;
- under the Arysta Sale Agreement, we are subject to certain restrictions on the conduct of our business prior to the closing of the Announced Arysta Sale, which restrictions could adversely affect our ability to realize certain of our business strategies or take advantage of certain business opportunities;
- the current trading price of our common stock may reflect a market assumption that the Announced Arysta Sale will be completed, and may be materially impacted if the closing of the Announced Arysta Sale is delayed or the transaction completed under different, less favorable terms, or if the Arysta Sale Agreement is terminated; and
- the attention of our management may be directed toward the closing of the Announced Arysta Sale and related matters, and their focus may be diverted from the day-to-day business operations of our Company, including from other opportunities that might otherwise be beneficial to us.
Upon closing of the Announced Arysta Sale, we intend to implement a reorganization, which could negatively impact our performance.
Upon the closing of the Announced Arysta Sale, we intend to change Platform’s portfolio management approach to a “one-company” structure. This reorganization is expected to remove our “corporate” holding company framework by combining our corporate functions with those of our Performance Solutions segment and creating a single operating unit. This reorganization could disrupt our operations and cause the loss of key personnel. We cannot guarantee that this new company structure will succeed or that we will be effective in executing the reorganization. Further, even if the reorganization is successful, we cannot guarantee that the new company structure will generate the cost savings and efficiencies that we anticipate. Failure to implement the reorganization or the new company structure successfully, on a timely basis, or at all, or failure to realize all, or any, of their intended benefits, may materially adversely affect our business, financial condition or results of operations.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-04-01 to 2018-06-30 | $1.02bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2018-01-01 to 2018-06-30 | $1.99bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2018-04-01 to 2018-06-30 | $599.6m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2018-01-01 to 2018-06-30 | $1.16bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2018-04-01 to 2018-06-30 | $422.9m | us-gaap:GrossProfit |
| Gross profit | 6 months2018-01-01 to 2018-06-30 | $827.6m | us-gaap:GrossProfit |
| Research and development | 3 months2018-04-01 to 2018-06-30 | $25.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2018-01-01 to 2018-06-30 | $49.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2018-04-01 to 2018-06-30 | $280.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2018-01-01 to 2018-06-30 | $557.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2018-04-01 to 2018-06-30 | $117.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2018-01-01 to 2018-06-30 | $221.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2018-04-01 to 2018-06-30 | −$14.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2018-01-01 to 2018-06-30 | $50.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 6 months2018-01-01 to 2018-06-30 | $49.8m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2018-04-01 to 2018-06-30 | $0.04 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2018-01-01 to 2018-06-30 | $0.17 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2018-04-01 to 2018-06-30 | $0.04 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2018-01-01 to 2018-06-30 | $0.17 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2018-04-01 to 2018-06-30 | 298,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2018-01-01 to 2018-06-30 | 297,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2018-01-01 to 2018-06-30 | −$91.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2018-01-01 to 2018-06-30 | $24.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2018-06-30 | $442.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-06-30 | $2.50bn | us-gaap:AssetsCurrent |
| Total assets | At period end2018-06-30 | $9.98bn | us-gaap:Assets |
| Current liabilities | At period end2018-06-30 | $1.19bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-06-30 | $7.37bn | us-gaap:Liabilities |
| Current portion of debt | At period end2018-06-30 | $138.8m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2018-06-30 | $2.53bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001590714-18-000081. Last ingested by Listed: Nov 10, 2026, 23:30 ET. Listed shows no prices and gives no investment advice.